(2) CJC-1295 CJC-1295 is a synthetic peptide designed to stimulate the release of growth hormone (GH) to help improve muscle development, metabolize fat, improve ones energy levels, and recover quicker after intensive workouts or injuries
Targets nicotinamide N-methyltransferase (NNMT)
At BHRC, our physicians use 5-Amino-1MQ as part of comprehensive metabolic optimization protocols, tailored to individual patient needs and health goals
Journal of Orthopaedic Research, 2016

Heres what you need to know: Target Tissue: Works specifically on adipose tissue without systemic growth hormone effects or muscle tissue impact Mechanism: Activates beta-3 adrenergic receptors on fat cell membranes, triggering intracellular fat-burning cascades Primary Action: Stimulates hormone-sensitive lipase to break down stored triglycerides into free fatty acids for energy utilization Secondary Action: Inhibits lipogenic enzymes that convert excess calories into stored fat Regional Selectivity: Particularly effective on visceral (deep abdominal) and subcutaneous fat deposits with high beta-3 receptor concentration Preservation Effect: Targets fat tissue selectively without promoting muscle protein breakdown or affecting lean tissue Unique Advantage: Does not bind to growth hormone receptors, avoiding effects on IGF-1, glucose metabolism, or insulin sensitivity Research Validation: Clinical trials with 900+ participants confirmed selective fat metabolism effects with excellent safety profile The following guide provides detailed analysis of how AOD-9604 targets fat cells, from receptor binding to metabolic outcomes

Body-weight changes do not reveal long-term safety